Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Thu, 07/30/2020 - 16:14	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Thu, 07/30/2020 - 14:11	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Anonymous
Newsletter opened	Thu, 07/30/2020 - 13:33	Opened		Anonymous
Newsletter opened	Thu, 07/30/2020 - 13:25	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind newsletter		Anonymous

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Thu, 07/30/2020 - 16:14	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Thu, 07/30/2020 - 14:11	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonymous
User created	Wed, 10/12/2022 - 13:23	User created		Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Anonymous
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Anonymous
Newsletter opened	Thu, 07/30/2020 - 13:33	Opened		Anonymous
Newsletter opened	Thu, 07/30/2020 - 13:25	Opened		Anonymous
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind newsletter		Anonymous

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER